Justyna Broniarczyk

Justyna Broniarczyk

Auto-generated profile, based on publicly available information

Justyna Broniarczyk

Department of Molecular Virology, Adam Mickiewicz University

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2015 in Viruses
Verified
Journal Article
Open access
PDF file
KGKetaki Ganti
Ketaki Ganti
JBJustyna Broniarczyk
Justyna Broniarczyk
WMWiem Manoubi
Wiem Manoubi
PMPaola Massimi
Paola Massimi
SMSuruchi Mittal
Suruchi Mittal
LBLawrence Banks
Lawrence Banks
Cancer-causing HPV E6 oncoproteins are characterized by the presence of a PDZ binding motif (PBM) at their extreme carboxy terminus. It was long thought that this region of E6 had a sole function to confer interaction with a defined set of cellular substrates. However, more recent studies have shown that the E6 PBM has a complex pattern of regulation, whereby phosphorylation within the PBM can regulate interaction with two classes of cellular proteins: those containing PDZ domains and the members of the 14-3-3 family of proteins. In this review, we explore the roles that the PBM and its ligands play in the virus life cycle, and subsequently how these can inadvertently contribute towards the development of malignancy. We also explore how subtle alterations in cellular signal transduction pathways might result in aberrant E6 phosphorylation, which in turn might contribute towards disease progression.

24 December 2022 in Molecules
Verified
Journal Article
Open access
PDF file
MWMagdalena Woźniak
Magdalena Woźniak
ASAnna Sip
Anna Sip
Lucyna MrówczyńskaLucyna Mrówczyńska
Lucyna Mrówczyńska
JBJustyna Broniarczyk
Justyna Broniarczyk
AWAgnieszka Waśkiewicz
Agnieszka Waśkiewicz
Izabela RatajczakIzabela Ratajczak
Izabela Ratajczak
Propolis is one of the bee products, with multiple biological properties used in numerous applications. The research objective was to determine the chemical composition and biological properties (antibacterial, antifungal, antiviral, antioxidant, and cytoprotective activity) of propolis extracts collected from various regions of Poland. The results indicated that the total content of phenols (116.16–219.41 mg GAE/g EEP) and flavonoids (29.63–106.07 mg QE/g EEP) in propolis extracts depended on their geographic origin. The high content of epicatechin, catechin, pinobanksin, myricetin, and acids: vanillic and syringic in propolis samples was confirmed by chromatographic analysis. Moreover, the presence of caffeic acid phenethyl ester was confirmed in all samples. The origin of propolis also influenced the biological properties of its extracts. The propolis extracts were characterized by moderate DPPH free radical scavenging activity (29.22–35.14%), and relatively low ferrous iron chelating activity (9.33–32.32%). The results indicated also that the propolis extracts showed high activity in the protection of human red blood cells against free radicals generated from 2,2’-azobis(2-methylpropionamidine) dihydrochloride (AAPH). The extracts exhibited diversified activity against the tested pathogenic bacteria and limited activity against fungal strains. The research of selected propolis extracts showed that only 2 of 5 examined samples showed moderate activity against HPV (human papillomaviruses) and the activity depended on its geographical distribution.

23 March 2011 in Clinical Epigenetics
Verified
Journal Article
Open access
EPElzbieta Poreba
Elzbieta Poreba
JBJustyna Karolina Broniarczyk
Justyna Karolina Broniarczyk
AGAnna Gozdzicka-Jozefiak
Anna Gozdzicka-Jozefiak
About 15–20% of human cancers worldwide have viral etiology. Emerging data clearly indicate that several human DNA and RNA viruses, such as human papillomavirus, Epstein–Barr virus, Kaposi’s sarcoma-associated herpesvirus, hepatitis B virus, hepatitis C virus, and human T-cell lymphotropic virus, contribute to cancer development. Human tumor-associated viruses have evolved multiple molecular mechanisms to disrupt specific cellular pathways to facilitate aberrant replication. Although oncogenic viruses belong to different families, their strategies in human cancer development show many similarities and involve viral-encoded oncoproteins targeting the key cellular proteins that regulate cell growth. Recent studies show that virus and host interactions also occur at the epigenetic level. In this review, we summarize the published information related to the interactions between viral proteins and epigenetic machinery which lead to alterations in the epigenetic landscape of the cell contributing to carcinogenesis.

27 March 2023 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
Aleksander EjsmontAleksander Ejsmont
Aleksander Ejsmont
AWAlicja Warowicka
Alicja Warowicka
JBJustyna Broniarczyk
Justyna Broniarczyk
Joanna GoscianskaJoanna Goscianska
Joanna Goscianska
The nanosized Cu-MOF/hydroxychloroquine systems reduce the infectivity of SARS-CoV-2 by the viral Spike protein–ACE2 receptor binding inhibition, the presence of copper in the MOF nodes, and the semi-controlled release of the drug.

11 March 2014 in Oncology Letters
Verified
Journal Article
Open access
PDF file
JBJustyna K. Broniarczyk
Justyna K. Broniarczyk
AWAlicja Warowicka
Alicja Warowicka
AKAnna Kwaśniewska
Anna Kwaśniewska
MWMaria Wohuń-Cholewa
Maria Wohuń-Cholewa
WKWojciech Kwaśniewski
Wojciech Kwaśniewski
AGAnna Goździcka-Józefiak
Anna Goździcka-Józefiak
Our previous study demonstrated a decreased expression of tumor susceptibility gene 101 (TSG101) in cervical cancer cells. To identify the mechanism responsible for TSG101 downregulation during cervical cancer development, we analyzed the TSG101 promoter using cis-element cluster finder software. One of the transcription factors whose binding site was detected in the TSG101 promoter was late SV40 factor (LSF). The aim of this study was to analyze the TSG101 protein and LSF expression levels during cervical cancer development. Immunohistochemical analysis confirmed a previously observed decreased expression of TSG101, whereas quantitative polymerase chain reaction (qPCR) and immunohistochemistry analysis revealed high expression of LSF in cervical, precancer and cancer cells compared with human papillomavirus (HPV)-negative non-cancer samples. High expression of LSF in cervical cancer HPV-positive cells suggests that this protein may be important in the regulation of TSG101 expression, as well as in cervical carcinogenesis. The role of LSF as a mediator in cervical cancer development must be confirmed in future studies.

30 March 2010 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
JBJ Broniarczyk
J Broniarczyk
Human papillomavirus (HPV)-mediated transformation of human epithelial cells has been recognized as a multi-step process in which additional unknown factors and (epi)genetic events are required. The tumor susceptibility gene 101 (TSG101) was discovered in mouse NIH3T3 fibroblast cells as a gene whose functional knockout leads to transformation. TSG101 protein is involved in a variety of important biological functions, such as ubiquitination, transcriptional regulation, endosomal trafficking, virus budding, proliferation and cell survival. It is suggested that TSG101 is an important factor for maintaining cellular homeostasis and that perturbation of TSG101 functions leads to cell transformation. Interestingly, a recent report showed up- or down-regulation of TSG101 in several human malignancies. At present, the role of TSG101 in cervical tumorigenesis is unexplained. TSG101 expression in tumors, where carcinogenesis is connected with viral infection, and a mechanism of TSG101 expression regulation in cancer cells are also unknown. The aim of our study was to estimate the TSG101 mRNA and protein level in cervical cancer and non-tumor epithelial cells. We also analyzed the TSG101 coding and promoter sequence using the PCR-SSCP technique and methylation pattern of the TSG101 promoter. Our real-time PCR and Western blot analysis showed decreased TSG101 mRNA and protein level in cervical cancer tissue in comparison to normal (non-tumor) HPV(-) and HPV16(+) epithelial cells. Our results suggest that TSG101 down-regulation in cervical cancer cells is not regulated by genetic or epigenetic events. However, we detected novel single nucleotide polymorphisms in the promoter of this gene.